跳到正文
原文
STAT· @statnews · X·· 7 天前精选AI 评分75
AI 导读

FDA 警告 GLP-1 药物存在一种罕见但严重眼病的潜在风险,并要求制药企业将该风险告知患者和医生。相关报道链接为 https://www.statnews.com/2026/11/09/glp-1-drugs-potential-risk-rare-eye-condition-naion-fda/。

推荐理由

FDA 就 GLP-1 药物与一种罕见严重眼病的潜在关联发出警示,并强制企业在标签中告知患者与医生。

正文

The Food and Drug Administration warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition and required pharma companies to inform patients and doctors of the risk. https://www.statnews.com/2026/11/09/glp-1-drugs-potential-risk-rare-eye-condition-naion-fda/

来源:STAT · x.com